Skip to content

COVID@Home: cardiovascular disease and risk in non-hospitalized Covid-19 patients

COVID@Home: cardiovascular disease and risk in non-hospitalized Covid-19 patients - COVID@Home

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51240
Enrollment
100
Registered
2021-09-16
Start date
2021-10-29
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID@Home

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants of the Rotterdam Study who recovered from a Covid-19 infection at home.

Exclusion criteria

Exclusion criteria: Participants with prior known myocardial infarction (based on the information previously collected within the Rotterdam Study from the GP registries) and/or eGFR

Design outcomes

Primary

MeasureTime frame
Cardiac MRI parameters

Secondary

MeasureTime frame
Parameters for cardiac structure en function. Also: - Blood makers, including lipids (total cholesterol, HDL-cholesterol and triglycerides), glucose, CRP, Creatinine, Troponin I or T, NT-proBNP) - Data collected from questionnaires, e.g. covid-related symptoms and fatigue - Cardiovascular risk factors Other study parameters: Sleep and activity: - Sleep (Total sleep time, Sleep onset latency, Wake after sleep onset, Sleep efficiency) - 24-hour activity rhythms (Interdaily stability, Intradaily variability, Onset lowest hours of activity) - Mental health

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)